- Report
- May 2024
- 135 Pages
Global
From €5915EUR$6,499USD£5,071GBP
- Report
- June 2024
- 200 Pages
Global
From €7235EUR$7,950USD£6,203GBP
- Report
- January 2022
- 60 Pages
Global
From €3595EUR$3,950USD£3,082GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1820EUR$2,000USD£1,560GBP
The Astigmatism Drug market is a subset of the Optical Disorders Drugs market, which includes drugs used to treat vision-related disorders. Astigmatism is a common eye condition that causes blurred vision due to an irregularly shaped cornea. Astigmatism Drugs are used to correct the shape of the cornea and improve vision. These drugs are typically administered topically, either as eye drops or ointments.
Astigmatism Drugs are used to treat a variety of vision-related disorders, including myopia, hyperopia, and presbyopia. These drugs are also used to treat astigmatism-related conditions such as amblyopia and strabismus. In addition, Astigmatism Drugs are used to treat eye infections and inflammation.
Some companies in the Astigmatism Drug market include Allergan, Bausch + Lomb, Novartis, Pfizer, and Santen Pharmaceuticals. Show Less Read more